- Home
- BNTX vs CAH Comparison
BNTX vs CAH Comparison
Compare BNTX & CAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNTX
- CAH
- Stock Information
- Founded
- BNTX 2008
- CAH 1979
- Country
- BNTX Germany
- CAH United States
- Employees
- BNTX N/A
- CAH N/A
- Industry
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- CAH Other Pharmaceuticals
- Sector
- BNTX Health Care
- CAH Health Care
- Exchange
- BNTX Nasdaq
- CAH Nasdaq
- Market Cap
- BNTX 25.0B
- CAH 36.7B
- IPO Year
- BNTX 2019
- CAH N/A
- Fundamental
- Price
- BNTX $106.47
- CAH $167.47
- Analyst Decision
- BNTX Strong Buy
- CAH Buy
- Analyst Count
- BNTX 18
- CAH 15
- Target Price
- BNTX $141.55
- CAH $154.07
- AVG Volume (30 Days)
- BNTX 1.1M
- CAH 2.3M
- Earning Date
- BNTX 08-04-2025
- CAH 08-13-2025
- Dividend Yield
- BNTX N/A
- CAH 1.22%
- EPS Growth
- BNTX N/A
- CAH 155.27
- EPS
- BNTX N/A
- CAH 6.38
- Revenue
- BNTX $2,968,331,171.00
- CAH $222,286,000,000.00
- Revenue This Year
- BNTX N/A
- CAH N/A
- Revenue Next Year
- BNTX $10.68
- CAH $10.96
- P/E Ratio
- BNTX N/A
- CAH $26.32
- Revenue Growth
- BNTX 0.61
- CAH 0.86
- 52 Week Low
- BNTX $76.53
- CAH $93.17
- 52 Week High
- BNTX $131.49
- CAH $168.39
- Technical
- Relative Strength Index (RSI)
- BNTX 53.76
- CAH 73.21
- Support Level
- BNTX $102.57
- CAH $161.57
- Resistance Level
- BNTX $107.51
- CAH $165.00
- Average True Range (ATR)
- BNTX 2.83
- CAH 3.01
- MACD
- BNTX -0.25
- CAH 0.21
- Stochastic Oscillator
- BNTX 56.58
- CAH 95.17
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.
About CAH Cardinal Health Inc.
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.